AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED
By:
Kahn Swick & Foti, LLC via
Business Wire
May 04, 2023 at 21:37 PM EDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amedisys, Inc. (NasdaqGS: AMED) to Option Care Health, Inc. ("Option Care") (NasdaqGS: OPCH). Under the terms of the proposed transaction, shareholders of Amedisys will receive 3.0213 shares of Option Care for each share of Amedisys that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-amed/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230504006133/en/ Contacts
Kahn Swick & Foti, LLC
More NewsView MoreVia MarketBeat
Tickers
PLTR
The $100 Million Tell: Following Smart Money Into DoorDash ↗
Today 7:37 EST
Via MarketBeat
Wall Street’s Sleeping Giant: Is Amazon About to Wake Up? ↗
December 02, 2025
Via MarketBeat
Checkmate in the Cloud: ServiceNow's Shopping Spree ↗
December 02, 2025
Via MarketBeat
The Contrarian Case for MSTR Amid MSCI Delisting Debacle ↗
December 02, 2025
Via MarketBeat
Tickers
MSTR
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|